Observational study on psoriasis and its risk for arthritis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The HIPPOCRATES Prospective Observational Study aims to identify patients with psoriasis who are at risk of developing psoriatic arthritis. Conducted across Europe, this study involves adults with psoriasis who will complete questionnaires every six months to monitor their condition. The research is led by the University of Oxford in collaboration with University College Dublin, focusing on understanding the progression from psoriasis to psoriatic arthritis. The ultimate goal is to prevent the onset of arthritis in at-risk individuals.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult ≥18 years
* Self-reported diagnosis of skin psoriasis (any form)
* Participant is willing and able to give informed consent for participation in the study and complete data in one of the HPOS languages

Exclusion Criteria:

• Pre-existing diagnosis of PsA

Where it's running

• Oxford University Hospital NHS Foundation Trust
  Oxford, Oxfordshire, United Kingdom Recruiting

Study contacts

• Study coordinator: Laura C Coates, MBChB, PhD
• Email: laura.coates@ndorms.ox.ac.uk
• Phone: 01865737838

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• TRAF3IP2 gene variation (rs13190932) in people with psoriasis and psoriatic arthritis

  This trial will test whether the TRAF3IP2 (rs13190932) gene variant changes how adults with psoriasis or psoriatic arthritis respond to methotrexate treatment.

  Recruiting South Valley University · Qina · NCT07086924

• Examining cytokine levels in psoriasis and psoriatic arthritis patients

  This study is trying to see how certain proteins in the blood and skin of people with psoriasis and psoriatic arthritis can help us understand these conditions better.

  Recruiting Poitiers University Hospital · Poitiers · NCT05307809

• Educational tool for melanoma patients with autoimmune diseases

  This study is testing a new educational tool to help melanoma patients with autoimmune diseases understand their treatment options better and see how easy it is for them to use.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT04751396

• Understanding chronic inflammatory systemic diseases and their treatments

  This study looks at patients with chronic inflammatory diseases to see how these conditions are related and how they can be treated better.

  Recruiting Centre Hospitalier Universitaire de Besancon · Besançon · NCT04191395

• Using nivolumab to treat patients with autoimmune disorders and advanced cancer

  This study is testing if nivolumab can safely help people with autoimmune disorders who also have advanced cancer by looking at how well it works and what side effects it might cause.

  Recruiting at 40 sites Phase 1 National Cancer Institute (NCI) · Birmingham, Alabama and 51 other locations · NCT03816345

• Monitoring pregnancy outcomes for women exposed to Stelara and Tremfya

  This study is tracking pregnancies in women who have used Stelara or Tremfya to see how these medications might affect the health and development of their babies.

  Recruiting University of California, San Diego · La Jolla, California · NCT02103361

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.